These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 7683002)
41. N-glycosylation as a biochemical basis for virulence in Leishmania mexicana amazonensis. Kink JA; Chang KP Mol Biochem Parasitol; 1988 Jan; 27(2-3):181-90. PubMed ID: 2830512 [TBL] [Abstract][Full Text] [Related]
42. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects. Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518 [TBL] [Abstract][Full Text] [Related]
43. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis. Mora AM; Mayrink W; Costa RT; Costa CA; Genaro O; Nascimento E Rev Inst Med Trop Sao Paulo; 1999; 41(4):243-8. PubMed ID: 10564919 [TBL] [Abstract][Full Text] [Related]
44. Novel 17-kilodalton Leishmania antigen revealed by immunochemical studies of a purified glycoprotein fraction recognized by murine T lymphocytes. Rodrigues MM; Xavier MT; Mendonça-Previato L; Barcinski MA Infect Immun; 1988 Jul; 56(7):1766-70. PubMed ID: 3260220 [TBL] [Abstract][Full Text] [Related]
45. [Production of monoclonal antibodies against Leishmania mexicana mexicana antigens]. Correnti M; Ortega G Acta Cient Venez; 1991; 42(4):226-8. PubMed ID: 1843566 [TBL] [Abstract][Full Text] [Related]
46. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Beyrodt CG; Pinto AR; Freymüller E; Barbiéri CL Infect Immun; 1997 Jun; 65(6):2052-9. PubMed ID: 9169731 [TBL] [Abstract][Full Text] [Related]
47. Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Kelleher M; Moody SF; Mirabile P; Osborn AH; Bacic A; Handman E Infect Immun; 1995 Jan; 63(1):43-50. PubMed ID: 7806383 [TBL] [Abstract][Full Text] [Related]
48. Insights into the tracking of the cysteine proteinase B COOH-terminal polypeptide of Leishmania (Leishmania) amazonensis by surface plasmon resonance. Santos-de-Souza R; Souza-Silva F; de Albuquerque-Melo BC; Ribeiro-Guimarães ML; de Castro Côrtes LM; Pereira BAS; Silva-Almeida M; Cysne-Finkelstein L; de Oliveira Junior FOR; Pereira MCS; Alves CR Parasitol Res; 2019 Apr; 118(4):1249-1259. PubMed ID: 30747292 [TBL] [Abstract][Full Text] [Related]
49. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Coelho EA; Tavares CA; Carvalho FA; Chaves KF; Teixeira KN; Rodrigues RC; Charest H; Matlashewski G; Gazzinelli RT; Fernandes AP Infect Immun; 2003 Jul; 71(7):3988-94. PubMed ID: 12819086 [TBL] [Abstract][Full Text] [Related]
51. Expression and size heterogeneity of a 63 kilodalton membrane glycoprotein during growth and transformation of Leishmania mexicana amazonensis. Chang CS; Inserra TJ; Kink JA; Fong D; Chang KP Mol Biochem Parasitol; 1986 Feb; 18(2):197-210. PubMed ID: 3515177 [TBL] [Abstract][Full Text] [Related]
52. Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. Leon LL; Machado GM; Barral A; de Carvalho-Paes LE; Grimaldi Júnior G Mem Inst Oswaldo Cruz; 1992; 87(2):229-34. PubMed ID: 1284990 [TBL] [Abstract][Full Text] [Related]
53. Flow cytometric analysis of the effects exerted by monoclonal antibodies on binding and uptake of Leishmania mexicana subsp. mexicana promastigotes by murine peritoneal macrophages. Williams KM; Sacci JB; Anthony RL Infect Immun; 1986 Apr; 52(1):36-44. PubMed ID: 3514462 [TBL] [Abstract][Full Text] [Related]
54. Ascorbate-Dependent Peroxidase (APX) from Leishmania amazonensis Is a Reactive Oxygen Species-Induced Essential Enzyme That Regulates Virulence. Xiang L; Laranjeira-Silva MF; Maeda FY; Hauzel J; Andrews NW; Mittra B Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527128 [TBL] [Abstract][Full Text] [Related]
55. A radioiodinated peptidyl diazomethane detects similar cysteine proteinases in amastigotes and promastigotes of Leishmania (L.) mexicana and L. (L.) amazonensis. Alfieri SC; Balanco JM; Pral EM Parasitol Res; 1995; 81(3):240-4. PubMed ID: 7770431 [TBL] [Abstract][Full Text] [Related]
56. Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes. Tonui WK; Ngumbi PM; Mpoke SS; Orago AS; Mbati PA; Turco SJ; Mkoji GM East Afr Med J; 2004 Feb; 81(2):97-103. PubMed ID: 15125094 [TBL] [Abstract][Full Text] [Related]
57. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Courret N; Prina E; Mougneau E; Saraiva EM; Sacks DL; Glaichenhaus N; Antoine JC Eur J Immunol; 1999 Mar; 29(3):762-73. PubMed ID: 10092078 [TBL] [Abstract][Full Text] [Related]
58. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection. Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018 [TBL] [Abstract][Full Text] [Related]
59. The major surface glycoprotein (GP63) is present in both life stages of Leishmania. Frommel TO; Button LL; Fujikura Y; McMaster WR Mol Biochem Parasitol; 1990 Jan; 38(1):25-32. PubMed ID: 2181303 [TBL] [Abstract][Full Text] [Related]
60. Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans. Buxbaum LU PLoS Negl Trop Dis; 2013; 7(5):e2224. PubMed ID: 23675550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]